N

Nanogroup SA
WSE:NNG

Watchlist Manager
Nanogroup SA
WSE:NNG
Watchlist
Price: 2.635 PLN -1.31% Market Closed
Market Cap: 86.5m PLN

Net Margin
Nanogroup SA

-9 940 700%
Current
-857 042.6%
Average
1.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-9 940 700%
=
Net Income
-9.9m
/
Revenue
100

Net Margin Across Competitors

No Stocks Found

Nanogroup SA
Glance View

NanoGroup SA engages in the medical research and development. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2017-12-21. The firm focuses on the investment in, as well as development of advanced biotechnological projects in the areas of cancer prevention, early diagnosis, targeted cancer therapies and ontological rehabilitation. Its projects portfolio includes NanoVelos, which is responsible for the creation of drug delivery system for proven oncologic medicines to optimize their performance; NanoSanguis, which develops artificial blood to keep alive patients wounded in accidents, as well as a system, named Organ farm, to preserve human organs ex vivo, and NanoThea, which is dedicated to technology that detects cancer cells in early stage.

NNG Intrinsic Value
Not Available
N
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-9 940 700%
=
Net Income
-9.9m
/
Revenue
100
What is the Net Margin of Nanogroup SA?

Based on Nanogroup SA's most recent financial statements, the company has Net Margin of -9 940 700%.

Back to Top